Strength
11 mg/1
Manufacturer
Pfizer Inc.NDC
00069050130
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
TOFACITINIB CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA208246On Market Since
3/7/2016
Pharmacological Classes
Janus Kinase Inhibitor
Janus Kinase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
OPZELURA 1.5% CREAM
Brand
50881000705•Incyte Corporation
$34.1433
per GM
OLUMIANT 2 MG TABLET
Brand
00002418230•Eli Lilly and Company
$92.2936
per EA
OLUMIANT 4 MG TABLET
Brand
00002447930•Eli Lilly and Company
$184.6623
per EA
CIBINQO 100 MG TABLET
Brand
00069033530•Pfizer Inc.
$197.1952
per EA
RINVOQ ER 30 MG TABLET
Brand
00074231030•AbbVie Inc.
$228.8254
per EA
RINVOQ ER 15 MG TABLET
Brand
00074230630•AbbVie Inc.
$229.2074
per EA
RINVOQ ER 45 MG TABLET
Brand
00074104328•AbbVie Inc.
$460.0432
per EA